entertainment -WSS

entertainment

author：hotspot 2025-10-02 23:30:22 - browse：88

An interface with a wire frame human on the center left, a human brain on the top right, a microscope on the bottom left, and some codes on both sides — coverage from STAT — Adobe

If the past year was prelude, the U.S. government in 2024 is poised to re-write the rules surrounding the use of artificial intelligence in health care.

Just in the past few months, President Joe Biden ordered a sweeping crackdown on AI by federal health agencies; members of Congress promised to step up oversight and pass new legislation; and many AI experts, from within industry and outside of it, sounded alarms about the urgent need for standards.

The heightened scrutiny is driven by rapid advances of generative AI tools such as ChatGPT. But makers of all kinds of predictive models may, for the first time, be required to explain how their systems were developed and tested — and prove that they are safe, reliable, and fair.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Study says nonprofit hospitals fall short in charity care spending

explore

WSS

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

In search for therapies for solid tumors, companies turn to claudin

Covid vaccine financial winners and losers, from Pfizer to Novavax

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

FogPharma raises $145 million in rare Series E round

focus

entertainment

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

ALS groups 'won't be played again' by the FDA, drug sponsors

Activists slam private health insurers over coverage restrictions

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Medicare proposal to cover medical devices draws a mixed reaction

Biotech companies concerned about China biosecurity crackdown

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Obesity now affects over 1 billion people worldwide, study finds

hotspot

Readout LOUD podcast: mifepristone case, GLP

Food as medicine: Medically tailored meals may get standardized

Merck drug for rare lung condition set for approval in U.S.

Scientists unlock the key to scar

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

knowledge

leisure time

explore

entertainment